About
Post Content
Patient Experience Underscores Market Potential for FDA-Cleared Scalp Cooling Device
According to a recent LinkedIn post from Cooler Heads, the company is highlighting a patient experience using its Amma scalp cooling device during chemotherapy. The…
Patient Experience Underscores Market Potential for FDA-Cleared Scalp Cooling Device Read More »
NY Medicaid Covers Scalp Cooling in Landmark Health Equity Move
New York Medicaid now funds a vital therapy to prevent chemo-induced hair loss, breaking down financial barriers for low-income cancer patients.
NY Medicaid Covers Scalp Cooling in Landmark Health Equity Move Read More »
Cooler Heads Enhances Cancer Treatment Access with Medicaid Coverage Expansion in New York
Cooler Heads has made significant strides in cancer care by securing Medicaid coverage for scalp cooling therapies in New York, improving patient access.
FDA Grants PMA Approval to LimiFlex® Dynamic Sagittal Tether
The U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) to the LimiFlex Dynamic Sagittal Tether , a motion-preserving system for the treatment of lumbar spinal stenosis associated with Grade I degenerative spondylolisthesis following decompression.
FDA Grants PMA Approval to LimiFlex® Dynamic Sagittal Tether Read More »
Koya Medical to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
CEO Andy Doraiswamy highlights the company’s growth and commercial momentum for its portfolio—including Dayspring®
Multi-Society Endorsed Position Statement Affirms the Clinical Value of Non-Pneumatic Compression in Lymphedema Management
NPCD endorsed by the American Venous Forum and the American Venous and Lymphatic Society as an effective option for lymphedema management.